Australia's most trusted
source of pharma news
Friday, 24 April 2026
Friday, 24 April 2026
Subscribe
Login
Lilly refuses PBS listing price
Despite finally winning a PBAC recommendation on its fourth attempt, Lilly has announced it will not make its blockbuster drug Mounjaro available on the PBS for Australians with type 2 diabetes after failing to secure a viable price.
RWE feud goes legal
Bayer and Johnson & Johnson go head-to-head in a US court over survival claims for two big prostate cancer drugs
TODAY
Jobs go in company restructure
ICYMI: Another company undergoes 'streamlining' with undisclosed job losses plus other popular stories this week
TODAY Your Week in 5 Minutes
Long-timers jumping companies
Seasoned pharma professionals from across industry are moving to new companies and new roles in the latest employment shifts
23 April
Aussie pharma naughty or nice?
Analysis of Medicines Australia complaint outcomes over three years reveals how often companies are breaching the Code of Conduct
23 April
One of industry's best moves on
Two-time PRIME Awards winner lands a new job outside industry at 'one of the fastest growing companies since Canva'
23 April
Final contender in MA Board race
Voting is now open to fill four vacancies on the Medicines Australia Board with an official count of 10 leaders in the running
22 April
Latest Jobs
StorepersonSenior Medical ManagerTrade Marketing ManagerTerritory Manager - SurgicalSenior Product ManagerAssistant AccoutantAssociate Marketing Manager - OTCInventory Team Supervisor24 more...
Pharma in Focus Jobs
Marketing & Communications (5)
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
Sales & Customer Relations (10)
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - East Ryde
- Hospital Specialist Representative - Melbourne
- Commercial Analytics & SFE Specialist - Sydney
Clinical & Medical, R&D (8)
- Senior Medical Manager - Melbourne
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Regulatory, Pharmacovigilance & QA (3)
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Executive Roles (1)
Other (8)
MD's message to Dept workers
An Australian pharma leader has made a pitch to public servants, laying out the case to change the way medicines are funded
TODAY
PBS a lever for medicine supply?
Geopolitical tensions are exposing the fragility of global supply chains but perhaps the PBS can help reduce Australia's vulnerability
TODAY
Boehringer shows its heart
Company steps up to support a program that takes healthcare to rural, regional, and remote areas of Australia
TODAY
Shortage looms on demand surge
Another shortage of this drug is on the horizon, with the TGA renewing a Serious Scarcity Substitution Instrument
23 April
Gene therapy finds footing in Aust
Who's secured a licence to conduct studies of its FDA-approved intravesical gene therapy in Australia?
23 April
From napkin to buyout in 10 years
An Australian pharma consulting firm with almost 500 market access projects under its belt now has international backing
22 April
J&J chases record-breaking sales
This company has set its sights on an ambitious goal of $100 billion in revenue this year... but analysts aren't so sure
22 April
Oncolytic immunotherapy cleared
CRO wins the go-ahead to conduct a clinical trial in Australia for Akamis Bio's lead drug candidate in rectal cancer
22 April
Another ex-Govt staffer joins MA
Former Chief of Staff to a Cabinet Minister and one-time newsman joins Medicines Australia, to steer Public Affairs and Govt Relations
22 April
Meet the most profitable pharma
The top 13 most profitable pharmas named with one company, which had an 83 per cent gross margin, branded the standout
21 April
Best drug name of 2026 goes to...
Pharma industry professionals have decided this year's best drug name in a nail-biting final championship round
21 April
Lung cancer drug wins wider label
Expanded approval for use as a combination therapy under the FDA's Project Orbis but it's already been knocked back by the PBAC
21 April
PBS rules preventing best practice
PBAC-imposed restrictions on PBS-listed drugs are preventing clinicians from prescribing the best treatment for their patients
21 April
Gilead builds a new revenue play
With half its revenue coming from a single product, this company is spending big to diversify its earnings
21 April